Typhoid Fever Vaccines Market is expected to reach US$ 525.32 Mn in 2027

Published Date: 23 Oct 2020

Report : Typhoid Fever Vaccines Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Vaccine Type (Live Attenuated Vaccine, Capsular Polysaccharide Vaccines, Conjugate Vaccine, Others); Route of administration (Oral, Injectable), and Geography.

Typhoid Fever Vaccines Market for Live Attenuated Vaccine to Grow At Highest CAGR during 2020–2027

 

According to our new market research study on “Typhoid fever vaccines Market to 2027 – Global Analysis and Forecast – by vaccine type and route of administration,” the market is expected to reach US$ 525.32 million by 2027 from US$ 262.81 million in 2019. The market is estimated to grow with a CAGR of 9.3% from 2020 to 2027. The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth.

 

Based on vaccine type, the market is segmented in to live attenuated vaccine, capsular polysaccharide vaccines, conjugate vaccine, and others.In 2019, the capsular polysaccharide vaccines segment accounted for the highest share of the market. Growth of this segment is attributed to the effectiveness associated with in preventing infections and increasing patient pool across the globe. The Live Attenuated Vaccine segment is likely to register highest CAGR in the global Typhoid fever vaccines market during the forecast period.

 

Global Typhoid fever vaccines Market, based on route of administration, the Typhoid fever vaccines market is segmented into oral and injections. The injectable segment held the largest share of the market in 2019, whereas the oral segment is anticipated to register the highest CAGR of 10.1% in the market during the forecast period.

 

COVID-19 pandemic has become the most significant challenge across the world. This challenge will be frightening especially in developing countries across the globe as it will lead to reducing imports due to disruptions in global trade, which further increases the shortages of medical supplies and other goods, resulting in a considerable price increase. The World Health Organization and UNICEF warned an alarming decline in the number of children receiving life-saving vaccines around the world. This is due to disruptions in the delivery and uptake of immunization services caused by the COVID-19 pandemic. In 2019, UNICEF procured an estimated 2.43 billion doses of vaccines to around 100 countries to reach around 45% of the world’s children below the 5-year-old age group.

 

Shanghai institute of biological products co., ltd., Bharat Biotech, Sanofi, GlaxoSmithKline, Paxvax Inc., PT Bio Farma, BIO-MED, Prokarium Ltd., Scandinavian Biopharma are among the leading companies operating in the Typhoid fever vaccines market.

 

Typhoid fever vaccines Market, by Region, 2019 (%)

Typhoid fever vaccines Market, by Region, 2019 (%)

 

The Report Segments Global Typhoid Fever Vaccines Market as Follows:

 

By Type

  • Live Attenuated Vaccine
  • Capsular Polysaccharide Vaccines
  • Conjugate Vaccine
  • Others


By Route of Administration     

  • Oral
  • Injections


By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of the Europe
  • Asia Pacific(APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Middle East & Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East and Africa
  • South America (SAM)
    • Brazil
    • Argentina
    • Rest of South America

Contact Us
Contact Person: Sameer Joshi 
Phone: +1-646-491-9876
 
Download PDF Brochure